OM: Outset Medical Inc Market Cap to Revenue Ratio

Symbol and logo of brand Outset (OM)

Outset Medical, Inc. (OM) is implementing Tablo systems with AI control for home dialysis. The P/S multiple dynamics on the GURU.Markets chart confirm this trend, where 0.60 expresses the metric's value today. However, geopolitical logistics disruptions and sanctions are limiting sales. Meanwhile, the company is successfully capturing the portable device niche, reducing clinic expenses and bypassing price competition.

Outset Medical (OM): P/S Multiple from 07/04/2022 to 11/13/2026

Metric breakdowns and analytics for Outset (OM)

- current quotes and average value forecast:
- market capitalization information:
Summary company analytics:outsetmedical.com, OM
Signature product of Outset Medical Corp

Outset Medical, Inc. (OM) is regaining its market position through loyalty to the Tablo system, making the analysis of market capitalization relative to sales volume critical for assessing business value. The current price-to-sales ratio measures the premium investors are willing to pay per unit of revenue, allowing for the identification of asset overvaluation and the forecasting of correction risks in the absence of stable revenue growth.

Competing companies

DXCM - Price to Sales|P/S Multiple PEN (Penumbra)|NOVT: Market Cap to Revenue Ratio|Haemonetics Corp. - P/S Multiple|Price-to-Revenue Coefficient Inspire Medical Systems Inc INSP|PRCT: P/S Multiple|Market Cap to Revenue conmed.com|PLSE (Pulse Biosciences) - P/S Multiple|P/S Multiple InMode Ltd|Price-to-Revenue Ratio Picard Medical Inc. (PMI)|Price-to-Revenue Ratio SRDX (Surmodics Inc.)|Senseonics Holdings - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio NPCE|Tactile Systems Technology Inc. - P/S Multiple|Price to Sales SANUWAVE Health|smartvest.com (ELMD) - Price-to-Revenue Ratio|Price-to-Revenue Multiple LENSAR Inc LNSR|Market Cap to Revenue RCEL|P/S Multiple Profound Medical Corporation|P/S Multiple BDMD|Price-to-Revenue Coefficient edap-tms.com|Price-to-Revenue Ratio Apyx Medical Corporation APYX|ICCM (IceCure Medical Ltd.) - Price-to-Sales Ratio|LUNG - Price-to-Revenue Ratio|TELA Bio, Inc. (TELA) - Market Cap to Revenue|CTSO: P/S Multiple|Price to Sales Sensus Healthcare Inc (SRTS)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue Ratio ECOR (electroCore Medical)|Market Cap to Revenue RBOT (Vicarious Surgical Inc.)|Market Cap to Sales Volume IINN|Price-to-Revenue Ratio SeaStar Medical ICU|IRIDEX Corp (IRIX) - Price to Sales|INBS: Market Cap to Revenue|XAIR - P/S Multiple|PFSA (Profusa Inc) - Market Cap to Revenue|SSKN: Market Cap to Sales Volume|Price-to-Revenue Ratio GlucoTrack, Inc.|nanovibronix.com (NAOV) - Price-to-Revenue Coefficient|P/S Multiple VERO|NUWE - Price to Sales|Aethlon Medical - Market Cap to Revenue|Market Cap to Sales Volume ASXC (Asensus Surgical Inc)|AVGR: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio BSGM (BioSig)|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Market Cap to Revenue Know Labs Corporation|NARI (Inari Medical, Inc.) - P/S Multiple|Price to Sales nevro.com NVRO|P/S Multiple RSLS|Silk Road Medical, Inc. - Market Cap to Revenue Ratio